Diabetic nephropathy (DN) is currently the most common cause of end-stage renal disease (ESRD). Although nowadays much is known about its classification, pathogenesis, clinical manifestations and evolution, to date we are not yet able to stop the natural progression of nephropathy in diabetic patients.
Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies / Pofi, Riccardo; Di Mario, Francesca; Gigante, Antonietta; Rosato, Edoardo; Isidori, Andrea; Amoroso, Antonio; Cianci, Rosario; Barbano, Biagio. - In: CURRENT DRUG METABOLISM. - ISSN 1875-5453. - STAMPA. - 17:5(2016), pp. 497-502.
Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies
POFI, RICCARDO;Di Mario, Francesca;GIGANTE, ANTONIETTA;ROSATO, Edoardo;ISIDORI, Andrea;AMOROSO, Antonio;CIANCI, ROSARIO;BARBANO, BIAGIO
2016
Abstract
Diabetic nephropathy (DN) is currently the most common cause of end-stage renal disease (ESRD). Although nowadays much is known about its classification, pathogenesis, clinical manifestations and evolution, to date we are not yet able to stop the natural progression of nephropathy in diabetic patients.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Pofi_diabetic-nephropathy_2016.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
220.92 kB
Formato
Adobe PDF
|
220.92 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
